ELN and Alzheimer disease: New tests that may confirm AD, such as those that measure soluble elastin fragments, smooth muscle myosin heavy chain, acute-phase reactants, such as the WBC count, high sensitivity CRP, fibrinogen, and D-dimer, are being developed [17].